4-HO-MPMI
Discover related
2 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Also known as | lucigenol | — | |
| Safety | |||
| Dose · Oral | |||
| Threshold | 500 µg | — | |
| Common | 1–2 µg | — | |
| Duration | |||
| Onset | 15–60 minutes | — | |
| Total | 6–8 hours | — | |
| Pharmacology | |||
| Receptor activity | — | Vasopressin V1a receptor | |
TripSit summary
A rare tryptamine derivative first synthesised by David Nichols. This drug, also known as lucigenol, has rarely been documented outside the lab. It is known to be a psychedelic similar to other psychoactive tryptamines, with a potency similar to DOI, but little else is known.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.